Wyeth Korea releases first-in-class antibiotic

Wyeth Korea, a Korean unit of Wyeth, has launched Tygacil (tigecycline) with an expanded broad spectrum of in vitro activity against many gram positives, gram negatives, anaerobes, methicillin-resistant and -susceptible Staphylococcus aureus and vancomycin-resistant enterococci.

Tygacil is the first clinically-available drug in a new class of antibiotics called the glycylcycline. This antibi...